Related Experiment Video
Updated: Sep 4, 2025
Transuterine Fetal Tracheal Occlusion Model in Mice
Published on: February 5, 2021
The Cellular and Molecular Effects of Fetoscopic Endoluminal Tracheal Occlusion in Congenital Diaphragmatic Hernia
Oluyinka O Olutoye Ii1,2, Walker D Short1,2, Jamie Gilley3
1Division of Pediatric Surgery, Department of Surgery, Texas Children's Hospital, Houston, TX, United States.
Insights
Fetoscopic endoluminal tracheal occlusion (FETO) improves lung development in congenital diaphragmatic hernia (CDH) patients. Further research into FETO
Area of Science:
- Developmental biology
- Pulmonary medicine
- Surgical innovation
Background:
- Congenital diaphragmatic hernia (CDH) causes underdeveloped lungs and high blood pressure in lung arteries.
- Fetoscopic endoluminal tracheal occlusion (FETO) is a prenatal procedure to enhance lung volume and morphology in CDH patients.
- The cellular and molecular impacts of FETO are not yet fully understood.
Purpose of the Study:
- To review the cellular and molecular effects of FETO on the developing lung.
- To identify research gaps in understanding CDH and FETO.
- To explore methods for optimizing FETO for better patient outcomes.
Main Methods:
- Literature review of studies on FETO and congenital diaphragmatic hernia.
- Analysis of cellular and molecular changes in lung development post-FETO.
- Synthesis of current research to identify future directions.
Main Results:
- FETO demonstrably improves lung volume and morphology.
- Cellular and molecular mechanisms underlying FETO's efficacy require further investigation.
- Optimizing FETO may enhance treatment strategies for CDH.
Conclusions:
- FETO offers significant prenatal benefits for CDH.
- Understanding the molecular basis of FETO is crucial for advancing CDH treatment.
- Further research can refine FETO protocols for improved postnatal outcomes.
Abstract:
Congenital diaphragmatic hernia (CDH) is a complex disease associated with pulmonary hypoplasia and pulmonary hypertension. Great strides have been made in our ability to care for CDH patients, specifically in the prenatal improvement of lung volume and morphology with fetoscopic endoluminal tracheal occlusion (FETO). While the anatomic effects of FETO have been described in-depth, the changes it induces at the cellular and molecular level remain a budding area of CDH research. This review will delve into the cellular and molecular effects of FETO in the developing lung, emphasize areas in which further research may improve our understanding of CDH, and highlight opportunities to optimize the FETO procedure for improved postnatal outcomes.
